(Q44136543)

30 November 2017

title

A limited sampling strategy for the estimation of 12-hour Neoral systemic drug exposure in heart transplant recipients (English)

1 reference

30 November 2017

C Balram

1

1 reference

30 November 2017

C Sivathasan

2

1 reference

30 November 2017

Yin Bun Cheung

3

1 reference

30 November 2017

Say Beng Tan

4

1 reference

30 November 2017

Yong Seng Tan

5

1 reference

30 November 2017

publication date

1 September 2002

1 reference

The Journal of Heart and Lung Transplantation

30 November 2017

published in

1 reference

30 November 2017

volume

21

1 reference

30 November 2017

issue

9

1 reference

30 November 2017

page(s)

1016-1021

1 reference

Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantation.

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900419-9

7 January 2021

High variability of drug exposure: a biopharmaceutic risk factor for chronic rejection

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900419-9

7 January 2021

A new microemulsion formulation of cyclosporin: pharmacokinetic and clinical features

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900419-9

7 January 2021

Optimization of cyclosporine therapy with new therapeutic drug monitoring strategies: report from the International Neoral TDM Advisory Consensus Meeting (Vancouver, November 1997).

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900419-9

7 January 2021

Challenges in cyclosporine therapy: the role of therapeutic monitoring by area under the curve monitoring.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900419-9

7 January 2021

A randomized, prospective multicenter pharmacoepidemiologic study of cyclosporine microemulsion in stable renal graft recipients. Report of the Canadian Neoral Renal Transplantation Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900419-9

7 January 2021

Prediction of creatinine clearance from serum creatinine

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900419-9

7 January 2021

The target concentration approach to clinical drug development.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900419-9

7 January 2021

The temporal profile of calcineurin inhibition by cyclosporine in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900419-9

7 January 2021

Prediction of acute graft rejection in renal transplantation: the utility of cyclosporine blood concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900419-9

7 January 2021

The adverse impact of high cyclosporine. Clearance rates on the incidences of acute rejection and graft loss

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900419-9

7 January 2021

Pharmacokinetic validation of neoral absorption profiling

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900419-9

7 January 2021

Comparative bioavailability of Neoral and Sandimmune in cardiac transplant recipients over 1 year

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900419-9

7 January 2021

Clinical benefit of neoral dose monitoring with cyclosporine 2-hr post-dose levels compared with trough levels in stable heart transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2900419-9

7 January 2021

10.1016/S1053-2498(02)00419-9

Identifiers

DOI

1 reference

30 November 2017

1 reference